Skip to main content

Table 3 Impact of NLPR on IVIG resistance

From: Predicting immunoglobulin resistance in Kawasaki disease: an assessment of neutrophil to lymphocyte platelet ratio

 

IVIG resistance

Unadjusted

Multiviable adjusteda

No

OR (95% CI) P

OR (95% CI) P

NLPR

74/803

1.14 (1.05, 1.24) 0.001

1.12 (1.00, 1.24) 0.040

T1 (< 0.555)

16/268

1.0 (reference)

1.0 (reference)

T2 (0.555–1.298)

18/267

1.14 (0.57, 2.30) 0.714

1.21 (0.58, 2.53) 0.611

T3 (≥ 1.298)

40/268

2.76 (1.53, 5.20) 0.001

2.59 (1.23, 5.58) 0.013

P for trend

< 0.001

< 0.001

0.010

  1. NLPR Neutrophil to lymphocyte platelet ratio, IVIG Intravenous immunoglobulin, CI Confidence interval, OR Odds ratio
  2. a Adjusted for age, sex, c-reaction protein, aspartate transaminase, alanine aminotransferase, serum albumin, sodium, and days of IVIG initiation ≤ 4